BEFORE ONE CAN prepare antagonists or antimetabolites for any physiologically active compound, it is necessary to gain some idea of the functional or necessary groups for biologic activity. With the smaller molecules, possessing fewer functional groups, the number of analogs is small as compared to those of larger polypeptide molecules with structures made more complex by their spatial arrangement or molecular conformation.
Our studies to determine the important side groups of angiotensin were beguni by synthesizing analogs of aspartyl-1-isoleucyl-5-angiotensin II, each of which would lack only 1 amino acid side group. This synthesis was accomplished by substituting alanine, the smallest optically active amino acid, for each of the amino acids of angiotensin, 1 at a time. The biologic activity of the analogs. as determin-ed in experiments by Khairallah. was compared for both pressor and oxytocie activity against the parent compound, angiotensin II. Schwyzer anid coworkers have likewise prepared angiotensin analogs, and the results obtained by both groups are presented here.
In figure 1 are shown the points of substitution in the angiotensin II molecule.
The importance of the various function-al groups is discussed below by starting with substitutions for aspartic acid and proceeding toward the C-terminus of angiotensin: In addition to the lack of importance of the N-terminal amino group, this evidence suggests that the angiotensin action is on a membrane surface.
The asparaginyl and aspartyl coinpounds have identical activities, while arginyl-langiotensin is somewhat depressed but still quite active.' It is evident that the acidic carboxyl group is not necessary for biologic activity. Even the heptapeptide without aspartic acid retains about 30 per cent of the pressor activity.2
Position 9: Since the hexapeptide (octapeptide minus amino acids 1 and 2) has slight pressor activity, it appears that position 2 is of little importance. Substantiating this conclusion is the fact that the nitroarginyl-2 and ornithyl-2 peptides3 retain considerable pressor activity.
Position 3: Replacement of valine with leucine had no effect on biologic activity.4
Position 4: Substitution of tyrosine in the hexapeptide with either phenylalanine or alanine results in a complete loss of activity.' Schwyzer stated (personal communication) that the phenylalanyl-4-angiotensin retains some pressor activity. Nevertheless, the phenolic hydroxyl is possibly involved in the combination between angiotensin and its receptor site.
Position 5: Valyl-5and isoleucyl-5-angiotensins have been isolated from bovine and horse (hog) blood, respectively. They appear to have equal biologie activity. This is to be expected since both amino acids have branching on the 1B carbon atom. Substitution of leucine in this position, however, considerably reduces the vasopressor activity of this polypeptide. Figure 1 port that angiotensin with its imidazole destroyed by photo-oxidation is almost completely inactive.5 Position 7: Alanyl-7-angiotensin retains about 1 per cent of the pressor activity of the parent compound.' Proline, an amino acid with a secondary amino group, cannot contribute to hydrogen bonding when it is in a peptide chain. It is likely that the alanyl-7-peptide has a different conformation from that of prolyl-7-angiotensin, which may account for the low biologic activity.
Position 8: The C-terminal amino acid seems to be the most important in angiotensins. The heptapeptide formed by removal of phenylalanine with carboxypeptidase is completely inactive. The complete lack of activity of alanyl-8-angiotensini shows the importance of the phenyl side residue in that position. That the free carboxyl group is necessary was shown by the very low activity of the octapeptide phenylalanine ester and amide.3 The very low activity of the decapeptide also suggests that a free carboxyl group is necessary on positioln 8.
Halverson et al. 6 report that angiotensin decapeptide is as active as the octapeptide in bloodless preparations of the toad. They suggest that it is not necessary to postulate hydrolysis of the decapeptide to the octa-peptide for pressor activity to result. It is possible, however, that an enzynme, contained intracellularly or absorbed on the surface of isolated muscle preparations, might convert angiotensin I to II. The degree of this conversion to angiotensin II was measured by the increase in oxytocie activity during the incubation of the decapeptide with homogenates of various tissues. As has been shown, 2 angiotensin octapeptide and the heptapeptide, Arg-Val-Tyr-Ileu-His-Pro-Phe, are the only peptides which could arise from angiotensin I that show significant oxytocie activity. Both of the peptides arise from the loss of the 2 amino acids from the C-terminus of angiotensin 1. Therefore, the measurement of the increase in oxytocic activity is an index of conversion.
Homogenates of heart, liver, aorta, and ileum convert the decapeptide to its active form, while a homogrenate of uterus does not.
This observation may explain the lack of activity of alngiotensin I on uterine musele. There is a difference, however, between the enizymes of those tissues which do carry out the conversion. Diisopropylfluorophosphate does not inihibit the plasnmaconvertinig enzynme or the converting enzyme of liver. It does inihibit that of aorta and, to a lesser extent, that obtained from heart Cireulation, Volume XXV, Janutary 1962 184 I 1 muscle. This suggests the possibility that plasma-converting enzyme is synthesized in the liver. Prolonged incubation of these tissue homogenates with angiotensin completely destroys all biologic activity.
Both urea and araininle in high concentrations inhibit the oxytocic activity of angiotensin almost completely. The inhibition is reversible. We have suggested that the reagents are changing the conformation of angiotensin and thereby reducing its biologic activity.
From these data, it appears that both amino acid sequence and peptide conformation are necessary for biologic activity. The amino acid side groups undoubtedly must exist in a spatial relation to one another in order to react with a specific receptor site. Discovering the important "reactive sites" of angiotensin is a long, tedious task but a necessary one if we are to understand the mechanism by which it acts.
Summary
The requirements for biologic activity of angiotensin II may be summarized from available data as follows: (1) a free Cterminal carboxyl group, (2) a phenyl group as a side group of amino acid number 8, (3) a phenolic group on amino acid number 4, (4) proline in position 7, (5) possibly a definite degree of spatial order, (6) at least 6 amino acids from the C-terminus, (7) possibly the imidazole of histidine in position 6.
